The University of Birmingham has launched a trial which could lead to a ground-breaking new way of treating people with two types of chronic liver disease. Up to 56 patients are being recruited to take part in the MERLIN trial, which will investigate the safety and efficacy of a new cellular immunotherapy in patients with […]
If you are not happy with the results below please do another search
Would you like to read a capsule summary of what the MERLIN project has accomplished? Well, please download and share the MERLIN Final Flyer here.
- The @FP7Merlin #clinicaltrial: NOW RECRUITING It is designed to: i) Determine dose safety of ORBCEL-C (selected Me… t.co/DNXAZmFZeK Time ago 23 Days via Twitter Web Client
- RT @unibirm_MDS: Project MERLIN, a new trial coordinated by @CRCTU @ImmunologyUoB, is recruiting up to 56 patients to investigate the safet… Time ago 34 Days via Twitter for iPhone
- RT @unibirm_MDS: A new cell therapy for chronic #liverdisease is being trialled as part of @fp7merlin by @CRCTU @ImmunologyUoB. It’s hoped… Time ago 38 Days via Twitter for iPhone
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.